MA41664A1 - Novel peptides and novel peptide combination for use in immunotherapy, and methods for generating scaffolds for use against pancreatic cancer and other cancers - Google Patents
Novel peptides and novel peptide combination for use in immunotherapy, and methods for generating scaffolds for use against pancreatic cancer and other cancersInfo
- Publication number
- MA41664A1 MA41664A1 MA41664A MA41664A MA41664A1 MA 41664 A1 MA41664 A1 MA 41664A1 MA 41664 A MA41664 A MA 41664A MA 41664 A MA41664 A MA 41664A MA 41664 A1 MA41664 A1 MA 41664A1
- Authority
- MA
- Morocco
- Prior art keywords
- peptides
- novel
- immunotherapy
- methods
- cancers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La présente invention concerne des peptides, des protéines, des acides nucléiques et des cellules à utiliser dans des procédés immunothérapeutiques. L'invention porte en particulier sur l'immunothérapie anticancéreuse. Cette invention concerne en outre des épitopes peptidiques de cellules t tumoraux, seuls ou combinés à d'autres peptides tumoraux, qui peuvent par exemple servir en tant que principes actifs pharmaceutiques de compositions vaccinales qui stimulent une réponse immunitaire antitumorale ou stimulent des cellules t ex vivo ensuite transférées à des patients. Des peptides liés aux molécules du complexe majeur d'histocompatibilité (cmh), ou des peptides en tant que tels, peuvent également être des cibles d'anticorps, des récepteurs de cellules t solubles et d'autres molécules de liaison.The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. The invention relates in particular to cancer immunotherapy. This invention further relates to peptide epitopes of tumor cells, alone or in combination with other tumor peptides, which can for example serve as pharmaceutical active ingredients of vaccine compositions which stimulate an antitumor immune response or stimulate ex vivo t cells. then transferred to patients. Peptides bound to major histocompatibility complex (cmh) molecules, or peptides as such, may also be antibody targets, soluble t cell receptors, and other binding molecules.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562182026P | 2015-06-19 | 2015-06-19 | |
| PCT/EP2016/063976 WO2016202963A2 (en) | 2015-06-19 | 2016-06-17 | Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA41664A1 true MA41664A1 (en) | 2018-07-31 |
Family
ID=59724549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA41664A MA41664A1 (en) | 2015-06-19 | 2016-06-17 | Novel peptides and novel peptide combination for use in immunotherapy, and methods for generating scaffolds for use against pancreatic cancer and other cancers |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR105011A1 (en) |
| EA (1) | EA202191013A3 (en) |
| MA (1) | MA41664A1 (en) |
-
2016
- 2016-06-15 AR ARP160101786A patent/AR105011A1/en unknown
- 2016-06-17 EA EA202191013A patent/EA202191013A3/en unknown
- 2016-06-17 MA MA41664A patent/MA41664A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA202191013A2 (en) | 2021-08-31 |
| AR105011A1 (en) | 2017-08-30 |
| EA202191013A3 (en) | 2021-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA44551A1 (en) | Novel peptides and novel combination of peptides for use in immunotherapy, and methods for generating scaffolds for use against pancreatic cancer and other cancers | |
| MA41521A1 (en) | Novel cell epitopes and new combination of cell epitopes for use in immunotherapy of myeloma and other cancers | |
| MA46647A1 (en) | New peptides and combination of peptides for use in immunotherapy of pancreatic cancer and other cancers | |
| MA44693B1 (en) | Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers | |
| MA43490A1 (en) | New peptides and combination of peptides for use in immunotherapy against various cancers | |
| MA46022B1 (en) | New peptides and peptide combination for use in immunotherapy against prostate cancer and other cancers | |
| MA43719B1 (en) | PEPTIDE FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND SMALL CELL LUNG CANCER | |
| MA41393A1 (en) | Novel peptides and peptide combinations and scaffolds formed therefor for use in immunotherapy against colorectal carcinoma (crc) and other cancers | |
| MA42381A (en) | NEW PEPTIDES AND NEW COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF ESOPHAGIC CANCER AND OTHER CANCERS | |
| MA41520B2 (en) | New peptides and peptide combination for use in immunotherapy against ovarian cancer and other cancers | |
| MA43435B1 (en) | NEW PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS (SEQ ID 25 - MRAX5-003) | |
| MA41237B1 (en) | New peptides and peptide combinations for use in immunotherapy against hepatocellular carcinoma (chc) and other cancers | |
| MA43090A1 (en) | Peptides, peptide combinations and cell-based drugs for immunotherapy against urinary bladder cancer and other cancers | |
| MA42294B1 (en) | New peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers | |
| MA43460A1 (en) | Novel peptides, peptide combinations and carriers for use in the immunotherapeutic treatment of various cancers | |
| MA43328A1 (en) | Transfected t-cells and t-cell receptors for use in immunotherapy against cancers | |
| MA43330A1 (en) | Transfected t-cells and t-cell receptors for use in immunotherapy against cancers | |
| MA47367B1 (en) | NOVEL PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS | |
| MA41664A1 (en) | Novel peptides and novel peptide combination for use in immunotherapy, and methods for generating scaffolds for use against pancreatic cancer and other cancers | |
| MA46913B1 (en) | New peptides and peptide combination for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers | |
| MA46503A1 (en) | New cell epitopes and novel combination of cell epitopes for use in immunotherapy of myeloma and other cancers | |
| MA43596A1 (en) | New peptides and novel combination of peptides for use in immunotherapy of esophageal cancer and other cancers |